Literature DB >> 21951595

British HIV Association guidelines for the treatment of TB/HIV coinfection 2011.

A L Pozniak1, K M Coyne, R F Miller, M C I Lipman, A R Freedman, L P Ormerod, M A Johnson, S Collins, S B Lucas.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21951595     DOI： 10.1111/j.1468-1293.2011.00954.x

Source DB:  PubMed          Journal:  HIV Med        ISSN： 1464-2662            Impact factor:   3.180


× No keyword cloud information.
  25 in total

1.  One-year mortality of HIV-positive patients treated for rifampicin- and isoniazid-susceptible tuberculosis in Eastern Europe, Western Europe, and Latin America.

Authors: 
Journal:  AIDS       Date:  2017-01-28       Impact factor: 4.177

2.  Conference report: pharmacogenomics in special populations at WCP2018.

Authors:  Guilherme Suarez-Kurtz; Eleni Aklillu; Yoshiro Saito; Andrew A Somogyi
Journal:  Br J Clin Pharmacol       Date:  2019-01-24       Impact factor: 4.335

3.  International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK.

Authors: 
Journal:  J Int AIDS Soc       Date:  2016-10-23       Impact factor: 5.396

4.  Relationship between weight, efavirenz exposure, and virologic suppression in HIV-infected patients on rifampin-based tuberculosis treatment in the AIDS Clinical Trials Group A5221 STRIDE Study.

Authors:  Anne F Luetkemeyer; Susan L Rosenkranz; Darlene Lu; Florence Marzan; Prudence Ive; Evelyn Hogg; Susan Swindells; Constance A Benson; Beatriz Grinsztejn; Ian M Sanne; Diane V Havlir; Francesca Aweeka
Journal:  Clin Infect Dis       Date:  2013-04-16       Impact factor: 9.079

5.  Effects of CYP2B6 and CYP1A2 Genetic Variation on Nevirapine Plasma Concentration and Pharmacodynamics as Measured by CD4 Cell Count in Zimbabwean HIV-Infected Patients.

Authors:  Doreen Mhandire; Miguel Lacerda; Sandra Castel; Kudakwashe Mhandire; Danai Zhou; Marelize Swart; Tinei Shamu; Peter Smith; Tutsirai Musingwini; Lubbe Wiesner; Babill Stray-Pedersen; Collet Dandara
Journal:  OMICS       Date:  2015-09

6.  Diagnosis and management of miliary tuberculosis: current state and future perspectives.

Authors:  Sayantan Ray; Arunansu Talukdar; Supratip Kundu; Dibbendhu Khanra; Nikhil Sonthalia
Journal:  Ther Clin Risk Manag       Date:  2013-01-08       Impact factor: 2.423

Review 7.  Challenges in the diagnosis & treatment of miliary tuberculosis.

Authors:  Surendra K Sharma; Alladi Mohan; Abhishek Sharma
Journal:  Indian J Med Res       Date:  2012-05       Impact factor: 2.375

8.  Comparison of screening strategies to improve the diagnosis of latent tuberculosis infection in the HIV-positive population: a cohort study.

Authors:  Katrina M Pollock; Herman Tam; Lisa Grass; Sharleen Bowes; Graham S Cooke; Manish Pareek; Damien Montamat-Sicotte; Moses Kapembwa; Graham P Taylor; Ajit Lalvani
Journal:  BMJ Open       Date:  2012-03-01       Impact factor: 2.692

9.  CD4+ cell count stratification to guide tuberculosis preventive therapy for people living with HIV.

Authors:  Lelia H Chaisson; Valeria Saraceni; Silvia Cohn; Dena Seabrook; Solange C Cavalcante; Richard E Chaisson; Jonathan E Golub; Betina Durovni
Journal:  AIDS       Date:  2020-01-01       Impact factor: 4.632

10.  When to start, what to start and other treatment controversies in pediatric HIV infection.

Authors:  Anna Turkova; Rachel H Webb; Hermione Lyall
Journal:  Paediatr Drugs       Date:  2012-12-01       Impact factor: 3.930
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.